UNSPSC 51411607: Propatylnitrate

This classification denotes a vasodilating agent with the molecular formula C6H11N3O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AJT2YN495R, chemically known as 1,3-propanediol, 2-ethyl-2-((nitrooxy)methyl)-, dinitrate (ester) but generally known as propatyl nitrate, which bears US NIH Compound Identifier 66261. European Medicines Agency schedules Propatylnitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10099MIG. The term PROPATYL NITRATE is an International Non-Proprietary Name.

World Health Organization schedules propatyl nitrate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule propatylnitrate under HS 29209085 and SITC 51639. SMILES: CCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]

UNSPSC 51411607 Propatylnitrate is a Commodity code that encompasses emergency medical medications and pharmaceutical supplies procured by state and local public safety agencies. State and local governments buy advanced life support medications under this code for use by fire rescue departments, emergency medical services, and other first-responder organizations. The solicitations under this code reflect procurement of specific pharmaceutical line items—vasopressors, antiarrhythmics, and other critical care injectables—with firm expiration-date requirements, cold-chain or stability warranties, and rapid delivery timelines typical of active emergency-response inventories. Issuing bodies include municipal fire departments and city purchasing offices acting on behalf of emergency services. The work involves goods procurement with strict pharmaceutical compliance, OSHA hazard communication documentation, and accessibility conformance reporting.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications to be used by Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The solicitation required four medication line items (Labetalol, Epinephrine, Adenosine, and Diltiazem) with nine-month minimum expiration dates, delivery within ten calendar days of order, and a one-year base term with two one-year renewal options plus three unilateral 30-day extension periods. The City offered a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount capped at $10,000. Recent activity under this code shows limited geographic concentration, with Florida municipalities driving visible procurement volume in emergency services pharmaceutical supply.